# Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding

> **NCT04358016** · PHASE4 · COMPLETED · sponsor: **Changhai Hospital** · enrollment: 54 (actual)

## Conditions studied

- Cirrhosis, Liver
- Upper Gastrointestinal Bleeding

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Somatostatin

## Key facts

- **NCT ID:** NCT04358016
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04358016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04358016, "Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04358016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*